FIELD: medicine.
SUBSTANCE: invention is characterised by a composition containing lactic acid and lactoferrin, or its peptide fragment, for treatment and/or prevention of the urogenital involvements, and by application of said composition for preparing a drug for treatment and/or prevention of the urogenital involvements, and also a method of treatment thereof. The method for prevention and/or treatment of the urogenital involvements caused by a bacterial or fungal infection, involves administration to the patient of a pharmaceutically effective amount of the composition containing lactic acid, or its salt, and lactoferrin, or its peptide fragment where said peptide fragment is based on an antimicrobial site of a lactoferrin molecule from an N-end.
EFFECT: invention provides the antimicrobial effect of application in the method for prevention and/or treatment with using said composition.
25 cl, 4 tbl, 8 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
PROBIOTIC STRAINS OF Lactobacillus (VARIANTS) AND THEIR USING | 2003 |
|
RU2316586C2 |
USE OF THIOSULPHATE IN ORDER TO POTENTIATE ANTI-PATHOGEN EFFECT OF LACTOBACILLUS | 2013 |
|
RU2667122C2 |
EFFERVESCENT COMPOSITION IN SOLID FORM FOR USE IN VAGINAL APPLICATIONS FOR TREATING VAGINAL INFECTIONS | 2012 |
|
RU2587717C2 |
BACTERIUM LACTOBACILLUS RHAMNOSUS FOR THE TREATMENT OF, FOR EXAMPLE, BACTERIAL VAGINOSIS | 2016 |
|
RU2758109C2 |
CULTURE MEDIUM FOR ISOLATION AND CULTIVATION OF LACTOBACILLUS INERS AND OTHER REPRESENTATIVES OF THE VAGINAL MICROBIOTA | 2022 |
|
RU2794804C1 |
PEPTIDES, DETACHED FROM HUMAN LACTOFERRIN, AND USE THEREOF | 2012 |
|
RU2593757C2 |
USE OF TOTAROL AND PHARMACEUTICAL COMPOSITION CONTAINING TOTAROL | 2018 |
|
RU2812223C2 |
LACTOBACILLUS CRISPATUS STRAIN FOR TREATMENT OR PREVENTION OF SEXUAL AND UROGENITAL INFECTIONS, SUCH AS VAGINOSIS AND CANDIDIASIS, AND USE THEREOF | 2013 |
|
RU2661102C2 |
NOVEL SYNTHETIC PEPTIDES AND USE THEREOF | 2012 |
|
RU2596393C2 |
PROBIOTIC STRAIN LACTOBACILLUS GASSERI AND ITS COMPOSITION WITH LACTOFERRIN FOR PREVENTION OF DIARRHEA, NERROCESSING ENTERHEROLITE AND SEPISIS CAUSED BY ESCHERICHIA COLI STRAINS IN PREMATURELY BORN CHILDREN | 2016 |
|
RU2641258C1 |
Authors
Dates
2010-09-10—Published
2005-06-23—Filed